News for Celldex Therapeutics, Inc. (TCE2.F)

Published at

Mar 5, 2021 7:00 PM

by thestreet.com

negative

negative

Celldex Therapeutics Announces Fireside Chat Presentation At The H.C. Wainwright Global Life Sciences Conference

HAMPTON, N.J., March 05, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) today announced the Company's participation in a fireside chat at the

TCE2.MU TCE2.F TCE2.BE CLDX

Read more →
Published at

Mar 3, 2021 1:46 PM

by benzinga.com

mixed

mixed

The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 2) ...

RMN.F RMN.BE MRK.PA MRK.MX MOR.F MOR.DE GSK.L GS7A.F GS7.SG GS7.MU GS7.F GS7.DE GS7.BE BSX.SG BSX.MX BSX.MU BSX.F BSX.BE 6MK.MU 6MK.F 6MK.DE 6MK.BE 4875.T 1OT.MU 1OT.F 1OT.BE TQ8.F TH.TO TCE2.MU TCE2.F TCE2.BE O2T.F O2T.BE E08A.F DPL.F CNB.F CNB.BE APH.SG APH.MU APH.F APH.BE 8STN.MU 8STN.F 8STN.BE 6GJ.F 69BN.SG 69BN.F 0OP.F 0OP.BE XP0.SG XP0.F RN3N.MU RN3N.F AMGN.BA AMG.MU AMG.F AMG.DE AMG.BE 2H0.MU 2H0.F 25K.SG 25K.MU 25K.F 25K.BE

Read more →
Published at

Feb 23, 2021 1:25 PM

by benzinga.com

mixed

mixed

The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 22) ...

XNCR XE9.SG XE9.MU XE9.F XE9.BE PLX.TA PLX PEN PBDA.MU PBDA.F PBDA.BE PAVM MGNX MDTN.MX MDT M55.F M55.BE JAZZN.MX JAZZ J7Z.SG J7Z.MU J7Z.F J7Z.BE HALO FREQ ARDS 2M6.MU 2M6.F 2M6.DE 2M6.BE 1P5.SG 1P5.F 0P8.MU 0P8.F XLRN VTGN VLON VCNX US972G108.F US972G108.BE TLIS TCE2.MU TCE2.F TCE2.BE TBPH SURF SLN RVNC RV7.MU RV7.F RV7.BE RUBY RTI.F RN3N.MU RN3N.F RDHL QSOA.MU QSOA.F QSOA.BE PODD PLRX PHVS PHAR MYGN MYD.SG MYD.MU MYD.F MYD.DE MYD.BE MASI.MX MASI INSP ICCC GOV.MU GOV.F GOV.BE GMTX ESPR EPZM EPE.F EPE.BE DMTK.MX DMTK CTXR CLVS CLDX CERC CELC C6O.MU C6O.F C6O.DE C6O.BE C6K.F BNR BLUE.MX BLUE BLE.MU BLE.F ATRC ARNA ANNX AMTI AKTX ADMS A5I.F 9PT.MU 9PT.F 5RT.SG 5RT.MU 5RT.F 5RT.BE 47N.F 3M4.MU 3M4.F 3M4.BE 2RH.MU 2RH.F 2RH.BE 2DR.MU 2DR.F 2DR.BE 23I.MU 23I.F 23I.BE 136.F 0ET.F 0A3.F UTHR UTH.SG UTH.MU UTH.F UTH.BE ONYN.F ONYN.BE ONCY ONCWF ONC.TO OM2.F OFIX NK MPH.L ITOS ITCI

Read more →
Published at

Feb 22, 2021 2:01 PM

by benzinga.com

negative

negative

Celldex Therapeutics to Present at 10th Annual SVB Leerink Global Healthcare Conference

HAMPTON, N.J., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the Company will participate in a fireside ...

TCE2.MU TCE2.F TCE2.BE CLDX

Read more →
Published at

Feb 19, 2021 1:25 PM

by benzinga.com

mixed

mixed

The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 19) ...

XCY.SG XCY.MU XCY.F XCY.BE QDEL OPK.TA OPK.MX OPK DTIL TCE2.MU TCE2.F TCE2.BE RI2A.MU RI2A.F RI2A.BE PRTA PFED.BA PFE.SG PFE.MX PFE.MU PFE.F PFE.DE PFE.BE PFE NVV1.MU NVV1.F NVV1.BE NVAX.MX NVAX NK MPH.L MJC.MU MJC.F EO7.MU EO7.F EO7.BE ENDP CBMG BNTXN.MX BNTX AVNS ANGN AMTI 8HH.MU 8HH.F 8HH.BE 7CB1.F 7CB1.BE 22UA.MU 22UA.F 22UA.DE 22UA.BE 0T22.SG 0T22.MU 0T22.F 0T22.BE 0PT.F UQ1.F UQ1.BE SANA RIGL RDY RDDA.MU RDDA.F RDDA.BE QURE LLY.SG LLY.F LLY.DE LLY.BA LLY DRREDDY.NS ALBPS.PA 6XB.F

Read more →
Published at

Feb 9, 2021 2:09 PM

by benzinga.com

mixed

mixed

The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 9) Abbott ...

VCYT VCEL RV7.MU RV7.F RV7.BE PPD NO1A.F NO1A.BE NAVB LGND LGDN.F LGDN.BE KRTX KALV JNCE ITOS ITCI IRWD INFI HALO GTHX GSK.L GS7A.F GS7.SG GS7.MU GS7.F GS7.DE GS7.BE GOVX GNPX GLAXF G1H.F G1H.BE FREQ FLGT.MX FLGT FGEN EVGN.TA EVGN EVAX ET82.SG ET82.MU ET82.F ET82.DU ET82.BE ENLV.TA ENLV EDAP EDA.F EDA.BE E8L.F DRNA DRIO DPL.F DMTK CXF.MU CXF.F CXF.BE CPTA.F CPTA.BE COLL CMRX CLGN CLDX CCXI AZRX AVIR AUTL ATQP.SG ATQP.MU ATQP.F ATQP.BE AEZS.TO AEZS ABT.SW ABT.MX ABT ABL.F ABL.DE ABBV 7F0.F 7F0.BE 6A3A.BE 4XC1.SG 4XC1.F 4XC1.BE 366.F 366.BE 354.F 2DE.F 2DE.BE 2CX.SG 2CX.MU 2CX.BE 23I.MU 23I.F 23I.BE 21J.SG 21J.MU 21J.F 21J.BE 1FG.F 1BT.F 1BT.BE 12V.F 12V.BE YP2A.F YP2A.BE VNDA VM4.SG VM4.F VIVO VERU US3528H109.F UG2.SG UG2.F UG2.BE TTOO TRIB TRBA.MU TPTX TERN TCE2.MU TCE2.F TCE2.BE TBIO SYBX SU6.F SU6.BE STRO SRDX SMMT SLRX SLN SIBN SESN SEEL S09.MU S09.F RNLX RENX.L RDUS RCUS RCKT QIA.SG QIA.MU QIA.F QIA.DE QIA.BE QGEN PRTK PRTA PROF PRN.TO PPBT.TA PPBT PLSE PCBK.MU PCBK.F PCBK.BE OTLK OT1A.MU OT1A.F OT1A.BE ORTX OPNT OCGN O7PA.MU O7PA.F NXEN.SG NXEN.F NXEN.BE NVV1.MU NVV1.F NVV1.BE NVAX.MX NVAX NOVN NK NBSE NARI N4CN.SG N4CN.F N4CN.BE MX9.F MSON MRNA MORF MJC.MU MJC.F MINA.MU MINA.F MINA.BE MGTA MEIP MDXG LIFE LHDX INSP INCY IMU.MU IMU.F IMU.DE IMU.BE IMGN IDYA ICY.MU ICY.F ICY.BE I76.F I3F.MU I3F.F I3F.BE HZNP HPR.MU HPR.F HBIO HBI.MU HBI.F GSK GMDA FP11.F FMW.MU FMW.F FMW.BE ETON DCPH D05.MU D05.F CSTL CCCC BOLT BLRX BEAM BCAB BBIO ATRS ATRC ANIX ANGO AMTI ALKS A5I.F 9IP1.MU 9IP1.F 6LU.F 6LU.BE 6L8.F 6L8.BE 471A.F 471A.BE 41ON.SG 41ON.MU 41ON.F 41ON.BE 3T2.MU 3T2.F 3T2.BE 3MT.MU 3MT.F 3MT.BE 31Y.MU 31Y.F 30J.MU 30J.F 30J.BE 2O9.F 2K3.MU 2K3.BE 2H51.F 2H51.BE 2DR.MU 2DR.F 2DR.BE 2CL.MU 2CL.F 1R8.SG 1R8.F 1R8.BE 0PT.F ZIOP XNCR XERS XE9.SG XE9.MU XE9.F XE9.BE WEK.SG WEK.MU WEK.F WEK.BE DYF1.MU DYF1.F DYF1.BE DVAX ANGN 2B3.MU 2B3.F 2B3.BE

Read more →
Published at

Feb 1, 2021 9:20 AM

by yahoo.com

mixed

mixed

AiCuris Changes its Legal Form: AiCuris Anti-infective Cures GmbH becomes AiCuris AG

Long history of success in fighting infectious diseases - ready for future growthAiCuris has been focusing on the identification and development of novel treatments to fight infectious diseases with high medical needs driven by understanding the indication and selecting the appropriate approach, since the Company was spun-out from Bayer's anti-infective unit in 2006. The Company's first product, Prevymis(R) (letermovir), a novel therapy for human cytomegalovirus (HCMV) infections is revolutionizing transplant medicine.

TCE2.MU TCE2.F TCE2.BE CLDX VSC.SG VSC.MU VSC.HM VSC.F VSC.DU VSC.DE VSC.BE MRK1N.MX MRK.SG MRK.MU MRK.F MRK.DE MRK.BE MKGAF

Read more →